Tracy A Rydel, MD
Family Practice · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rydel’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A93863 · Current
Licensed to practise in California · since 2006 · expires 2027-09-30 · Temple University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$8,137
Medicare paid this office $8,137 for 88 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 50 | $3,322 | $66 |
| Return visit (30+ min) | 23 | $1,728 | $54 |
| Short return visit (20+ min) | 11 | $610 | $47 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 12 | $165 | $14 |
Who their Medicare patients are
88 Original Medicare patients in 2024. Average age 73 · Women 67% · Also on Medicaid 28% · Health risk score 1.06. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 50% · Diabetes 27% · Atrial fibrillation 19% · Depression 16% · Chronic kidney disease 15% · Coronary heart disease 14%.
The office billed $58,522, Medicare allowed $10,626 and paid $8,137; for 144 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 88 | 144 | 73 | 1.06 | $58,522 | $8,137 |
| 2023 | 122 | 276 | 73 | 1.00 | $107,883 | $15,120 |
| 2022 | 103 | 265 | 73 | 0.90 | $107,889 | $14,202 |
| 2021 | 105 | 281 | 72 | 1.15 | $100,966 | $16,927 |
| 2020 | 100 | 233 | 72 | 1.22 | $50,557 | $13,635 |
| 2019 | 96 | 187 | 73 | 1.52 | $19,928 | $12,316 |
| 2018 | 106 | 209 | 72 | 1.29 | $21,490 | $13,306 |
| 2017 | 90 | 184 | 70 | 1.32 | $32,116 | $10,901 |
| 2016 | 102 | 242 | 71 | 1.11 | $49,660 | $15,149 |
| 2015 | 74 | 147 | 72 | 1.04 | $33,768 | $11,133 |
| 2014 | 82 | 188 | 73 | 1.21 | $49,671 | $14,005 |
| 2013 | 95 | 240 | 71 | 1.18 | $63,083 | $17,411 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 52 | $4,780 | $51 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 73 | $4,503 | $62 |
| Short return visit (20+ min) | 50 | $3,152 | $49 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $1,162 | $58 |
2022: 4 services
| Return visit (30+ min) | 58 | $5,615 | $49 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 45 | $2,297 | $51 |
| Short return visit (20+ min) | 32 | $2,281 | $50 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $1,002 | $56 |
2021: 6 services
| Return visit (30+ min) | 65 | $7,558 | $55 |
| Short return visit (20+ min) | 30 | $2,121 | $48 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $2,028 | $81 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 19 | $1,404 | $74 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $1,243 | $62 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,210 | $71 |
2020: 4 services
| Return visit (30+ min) | 74 | $8,625 | $62 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,976 | $68 |
| Short return visit (20+ min) | 18 | $1,042 | $47 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $902 | $41 |
2019: 1 service
| Return visit (30+ min) | 87 | $10,674 | $64 |
2018: 3 services
| Return visit (30+ min) | 75 | $7,160 | $59 |
| Return visit (30+ min) | 34 | $2,686 | $69 |
| Long return visit (40+ min) | 14 | $1,895 | $95 |
2017: 3 services
| Return visit (30+ min) | 74 | $7,562 | $58 |
| Long return visit (40+ min) | 22 | $2,347 | $81 |
| Short return visit (20+ min) | 15 | $413 | $26 |
2016: 3 services
| Return visit (30+ min) | 77 | $9,480 | $59 |
| Long return visit (40+ min) | 28 | $3,468 | $85 |
| Short return visit (20+ min) | 16 | $866 | $38 |
2015: 3 services
| Return visit (30+ min) | 43 | $5,256 | $67 |
| Long return visit (40+ min) | 24 | $3,081 | $99 |
| Short return visit (20+ min) | 16 | $956 | $46 |
2014: 3 services
| Return visit (30+ min) | 54 | $6,782 | $59 |
| Long return visit (40+ min) | 18 | $2,943 | $92 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,831 | $135 |
2013: 5 services
| Return visit (30+ min) | 69 | $9,545 | $59 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 17 | $3,376 | $199 |
| Long return visit (40+ min) | 14 | $1,576 | $72 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,467 | $133 |
| Short return visit (20+ min) | 13 | $855 | $39 |
Drugs they prescribed that Part D paid
$105,822
Pharmacies billed $105,822 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (72 of 1,029) in 2024. A higher opioid share than 9 in 10 peers; the typical family practice clinician is at 2%. Long-acting opioids: 47% of their opioid prescriptions.
925 generic and fewer than 11 brand-name prescriptions · $105,822 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 15 | $20,709 | $1,381 |
| Oxycontin | 14 | $12,719 | $908 |
| Ozempic | 13 | $11,435 | $880 |
| Buprenorphine | 13 | $5,171 | $398 |
| Testosterone | 12 | $2,160 | $180 |
See all 30 drugs
| Eliquis | 15 | $20,709 | $1,381 |
| Oxycontin | 14 | $12,719 | $908 |
| Ozempic | 13 | $11,435 | $880 |
| Buprenorphine | 13 | $5,171 | $398 |
| Testosterone | 12 | $2,160 | $180 |
| Rosuvastatin | 22 | $893 | $41 |
| Duloxetine | 11 | $711 | $65 |
| Atorvastatin | 72 | $689 | $10 |
| Escitalopram | 11 | $680 | $62 |
| Metoprolol | 20 | $535 | $27 |
| Omeprazole | 37 | $533 | $14 |
| Gabapentin | 27 | $512 | $19 |
| Hydrocodone-Acetaminophen | 20 | $462 | $23 |
| Diclofenac | 22 | $443 | $20 |
| Trazodone | 18 | $384 | $21 |
| Levothyroxine | 23 | $377 | $16 |
| Tamsulosin | 24 | $342 | $14 |
| Fluticasone Propionate | 22 | $273 | $12 |
| Losartan | 28 | $244 | $9 |
| Allopurinol | 29 | $242 | $8 |
| Finasteride | 17 | $228 | $13 |
| Lisinopril | 22 | $175 | $8 |
| Metformin | 25 | $174 | $7 |
| Zolpidem | 19 | $135 | $7 |
| Lorazepam | 19 | $104 | $5 |
| Amlodipine Besylate | 27 | $76 | $3 |
| Simvastatin | 13 | $47 | $4 |
| Lisinopril-Hydrochlorothiazide | 21 | $33 | $2 |
| Hydrochlorothiazide | 12 | $22 | $2 |
| Tramadol | 11 | $16 | $1 |
Year by year
| 2024 | 1,029 | 104 | 7% (72) | None | $105,822 |
| 2023 | 1,472 | 121 | 7% (107) | None | $180,600 |
| 2022 | 1,464 | 119 | 8% (115) | None | $158,334 |
| 2021 | 1,503 | 118 | 10% (144) | None | $173,370 |
| 2020 | 1,767 | 148 | 9% (162) | 12% | $177,253 |
| 2019 | 1,647 | 104 | 10% (164) | None | $154,024 |
| 2018 | 1,358 | 121 | 10% (130) | None | $121,018 |
| 2017 | 1,396 | 118 | 9% (131) | None | $117,445 |
| 2016 | 1,377 | 96 | 11% (157) | None | $85,026 |
| 2015 | 882 | 85 | 10% (85) | 12% | $38,419 |
| 2014 | 1,604 | 93 | 7% (115) | 13% | $85,750 |
| 2013 | 1,656 | 101 | 7% (111) | None | $97,414 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 45 drugs
| Eliquis | 43 | $38,653 | $899 |
| Oxycontin | 20 | $20,246 | $1,012 |
| Buprenorphine | 12 | $4,974 | $415 |
| Celecoxib | 15 | $4,184 | $279 |
| Klonopin | 24 | $2,297 | $96 |
| Trazodone | 50 | $1,745 | $35 |
| Atorvastatin | 81 | $1,737 | $21 |
| Duloxetine | 17 | $1,209 | $71 |
| Albuterol Sulfate Hfa | 13 | $874 | $67 |
| Ondansetron | 16 | $853 | $53 |
| Tamsulosin | 26 | $838 | $32 |
| Metoprolol | 25 | $812 | $32 |
| Gabapentin | 30 | $767 | $26 |
| Clotrimazole | 14 | $752 | $54 |
| Escitalopram | 15 | $735 | $49 |
| Metformin | 39 | $675 | $17 |
| Levothyroxine | 30 | $655 | $22 |
| Rosuvastatin | 21 | $646 | $31 |
| Losartan | 30 | $622 | $21 |
| Amlodipine Besylate | 29 | $595 | $21 |
| Mirtazapine | 16 | $537 | $34 |
| Omeprazole | 44 | $521 | $12 |
| Oxycodone | 27 | $512 | $19 |
| Fluticasone Propionate | 22 | $508 | $23 |
| Hydrocodone-Acetaminophen | 21 | $503 | $24 |
| Lisinopril | 26 | $430 | $17 |
| Glipizide | 14 | $393 | $28 |
| Simvastatin | 22 | $385 | $18 |
| Lorazepam | 26 | $374 | $14 |
| Diclofenac | 12 | $353 | $29 |
| Citalopram Hbr | 11 | $349 | $32 |
| Buprenorphine | 12 | $346 | $29 |
| Carvedilol | 12 | $330 | $28 |
| Finasteride | 19 | $316 | $17 |
| Sertraline | 13 | $276 | $21 |
| Prednisone | 14 | $260 | $19 |
| Allopurinol | 18 | $221 | $12 |
| Buspirone | 14 | $219 | $16 |
| Lovastatin | 13 | $154 | $12 |
| Hydrochlorothiazide | 18 | $148 | $8 |
| Atenolol | 12 | $141 | $12 |
| Zolpidem | 12 | $115 | $10 |
| Diazepam | 22 | $77 | $4 |
| Alprazolam | 11 | $76 | $7 |
| Lisinopril-Hydrochlorothiazide | 22 | $56 | $3 |
2022: 42 drugs
| Eliquis | 54 | $39,608 | $733 |
| Oxycontin | 17 | $14,989 | $882 |
| Klonopin | 24 | $2,874 | $120 |
| Atorvastatin | 71 | $1,316 | $19 |
| Trazodone | 39 | $1,231 | $32 |
| Duloxetine | 22 | $1,142 | $52 |
| Albuterol Sulfate Hfa | 17 | $1,132 | $67 |
| Oxycodone | 31 | $1,073 | $35 |
| Metoprolol | 26 | $939 | $36 |
| Estradiol | 12 | $889 | $74 |
| Spironolactone | 14 | $680 | $49 |
| Rosuvastatin | 24 | $677 | $28 |
| Levothyroxine | 30 | $664 | $22 |
| Ondansetron | 13 | $603 | $46 |
| Tamsulosin | 29 | $543 | $19 |
| Losartan | 39 | $540 | $14 |
| Metformin | 35 | $501 | $14 |
| Mirtazapine | 19 | $492 | $26 |
| Diclofenac | 13 | $474 | $36 |
| Amlodipine Besylate | 26 | $461 | $18 |
| Hydrocodone-Acetaminophen | 28 | $431 | $15 |
| Escitalopram | 12 | $423 | $35 |
| Finasteride | 23 | $411 | $18 |
| Mometasone Furoate | 11 | $403 | $37 |
| Gabapentin | 22 | $402 | $18 |
| Prednisone | 31 | $397 | $13 |
| Simvastatin | 27 | $395 | $15 |
| Diazepam | 30 | $383 | $13 |
| Diclofenac | 18 | $381 | $21 |
| Montelukast | 12 | $360 | $30 |
| Lisinopril | 30 | $312 | $10 |
| Allopurinol | 12 | $266 | $22 |
| Lorazepam | 26 | $256 | $10 |
| Glipizide | 21 | $243 | $12 |
| Omeprazole | 25 | $200 | $8 |
| Hydrochlorothiazide | 17 | $173 | $10 |
| Cyclobenzaprine | 22 | $172 | $8 |
| Buspirone | 17 | $158 | $9 |
| Furosemide | 11 | $80 | $7 |
| Lovastatin | 12 | $79 | $7 |
| Triamcinolone Acetonide | 12 | $75 | $6 |
| Lisinopril-Hydrochlorothiazide | 15 | $50 | $3 |
2021: 47 drugs
| Eliquis | 17 | $22,268 | $1,310 |
| Oxycontin | 20 | $14,023 | $701 |
| Buprenorphine | 18 | $8,090 | $449 |
| Linzess | 13 | $6,385 | $491 |
| Testosterone | 12 | $3,097 | $258 |
| Oxycodone | 35 | $1,776 | $51 |
| Fentanyl | 14 | $1,321 | $94 |
| Estradiol | 19 | $1,296 | $68 |
| Rosuvastatin | 25 | $1,161 | $46 |
| Trazodone | 39 | $1,123 | $29 |
| Atorvastatin | 60 | $1,095 | $18 |
| Diclofenac | 11 | $845 | $77 |
| Montelukast | 14 | $800 | $57 |
| Levothyroxine | 30 | $790 | $26 |
| Hydrocodone-Acetaminophen | 32 | $711 | $22 |
| Ondansetron | 18 | $683 | $38 |
| Losartan | 44 | $682 | $15 |
| Duloxetine | 17 | $675 | $40 |
| Metoprolol | 19 | $663 | $35 |
| Gabapentin | 42 | $636 | $15 |
| Cyclobenzaprine | 29 | $566 | $20 |
| Diclofenac | 18 | $554 | $31 |
| Amlodipine Besylate | 32 | $542 | $17 |
| Metformin | 33 | $417 | $13 |
| Tamsulosin | 28 | $402 | $14 |
| Simvastatin | 32 | $392 | $12 |
| Pantoprazole | 18 | $383 | $21 |
| Mirtazapine | 12 | $370 | $31 |
| Finasteride | 24 | $350 | $15 |
| Citalopram Hbr | 11 | $337 | $31 |
| Lisinopril | 34 | $321 | $9 |
| Fluticasone Propionate | 17 | $285 | $17 |
| Benazepril | 14 | $282 | $20 |
| Buprenorphine | 12 | $274 | $23 |
| Omeprazole | 30 | $269 | $9 |
| Fluoxetine | 14 | $215 | $15 |
| Alendronate | 13 | $193 | $15 |
| Escitalopram | 17 | $181 | $11 |
| Prednisone | 12 | $180 | $15 |
| Lorazepam | 28 | $173 | $6 |
| Amitriptyline | 14 | $128 | $9 |
| Diazepam | 21 | $124 | $6 |
| Tramadol | 12 | $106 | $9 |
| Hydrochlorothiazide | 17 | $94 | $6 |
| Buspirone | 19 | $78 | $4 |
| Furosemide | 15 | $75 | $5 |
| Lisinopril-Hydrochlorothiazide | 13 | $17 | $1 |
2020: 61 drugs
| Eliquis | 13 | $18,326 | $1,410 |
| Valganciclovir | 12 | $14,581 | $1,215 |
| Oxycontin | 20 | $13,860 | $693 |
| Buprenorphine | 15 | $6,571 | $438 |
| Linzess | 14 | $6,549 | $468 |
| Testosterone | 12 | $3,839 | $320 |
| Fentanyl | 18 | $2,218 | $123 |
| Oxycodone-Acetaminophen | 26 | $2,183 | $84 |
| Klonopin | 12 | $1,702 | $142 |
| Ondansetron | 24 | $1,550 | $65 |
| Duloxetine | 16 | $1,338 | $84 |
| Rosuvastatin | 29 | $1,319 | $45 |
| Atorvastatin | 72 | $1,298 | $18 |
| Ventolin Hfa | 18 | $1,260 | $70 |
| Celecoxib | 13 | $1,242 | $96 |
| Gabapentin | 63 | $1,107 | $18 |
| Oxycodone | 28 | $1,095 | $39 |
| Losartan | 56 | $686 | $12 |
| Trazodone | 29 | $685 | $24 |
| Hydrocodone-Acetaminophen | 31 | $639 | $21 |
| Diclofenac | 12 | $639 | $53 |
| Buprenorphine | 11 | $624 | $57 |
| Levothyroxine | 22 | $622 | $28 |
| Lisinopril | 52 | $617 | $12 |
| Pregabalin | 12 | $589 | $49 |
| Metoprolol | 18 | $587 | $33 |
| Ketoconazole | 13 | $543 | $42 |
| Escitalopram | 22 | $522 | $24 |
| Tamsulosin | 27 | $496 | $18 |
| Cyclobenzaprine | 28 | $483 | $17 |
| Tramadol | 14 | $479 | $34 |
| Metformin | 42 | $470 | $11 |
| Pantoprazole | 16 | $434 | $27 |
| Dicyclomine | 13 | $403 | $31 |
| Baclofen | 16 | $395 | $25 |
| Amlodipine Besylate | 34 | $389 | $11 |
| Mometasone Furoate | 11 | $360 | $33 |
| Citalopram Hbr | 13 | $356 | $27 |
| Spironolactone | 11 | $353 | $32 |
| Nystop | 11 | $322 | $29 |
| Montelukast | 17 | $321 | $19 |
| Alendronate | 18 | $280 | $16 |
| Simvastatin | 33 | $278 | $8 |
| Ibuprofen | 12 | $273 | $23 |
| Lorazepam | 39 | $268 | $7 |
| Triamcinolone Acetonide | 24 | $260 | $11 |
| Hydrochlorothiazide | 29 | $258 | $9 |
| Fluticasone Propionate | 15 | $239 | $16 |
| Finasteride | 15 | $226 | $15 |
| Zolpidem Tartrate Er | 14 | $219 | $16 |
| Lovastatin | 14 | $202 | $14 |
| Omeprazole | 28 | $196 | $7 |
| Carvedilol | 16 | $195 | $12 |
| Sumatriptan | 11 | $157 | $14 |
| Buspirone | 21 | $156 | $7 |
| Fluoxetine | 16 | $126 | $8 |
| Metoprolol | 14 | $117 | $8 |
| Allopurinol | 11 | $108 | $10 |
| Prednisone | 11 | $108 | $10 |
| Atenolol | 12 | $78 | $7 |
| Furosemide | 21 | $72 | $3 |
2019: 49 drugs
| Valganciclovir | 12 | $14,501 | $1,208 |
| Oxycontin | 21 | $12,701 | $605 |
| Testosterone | 12 | $3,782 | $315 |
| Ondansetron | 33 | $3,000 | $91 |
| Fentanyl | 18 | $2,149 | $119 |
| Oxycodone-Acetaminophen | 33 | $1,822 | $55 |
| Estradiol | 14 | $1,792 | $128 |
| Oxycodone | 22 | $1,526 | $69 |
| Atorvastatin | 56 | $1,347 | $24 |
| Trazodone | 39 | $854 | $22 |
| Hydrocodone-Acetaminophen | 46 | $823 | $18 |
| Metoprolol | 16 | $777 | $49 |
| Dicyclomine | 13 | $775 | $60 |
| Rosuvastatin | 19 | $752 | $40 |
| Gabapentin | 30 | $732 | $24 |
| Levothyroxine | 28 | $710 | $25 |
| Tamsulosin | 22 | $563 | $26 |
| Terazosin | 13 | $536 | $41 |
| Omeprazole | 38 | $508 | $13 |
| Baclofen | 17 | $478 | $28 |
| Metformin | 43 | $469 | $11 |
| Losartan | 50 | $467 | $9 |
| Fluoxetine | 13 | $452 | $35 |
| Pantoprazole | 13 | $443 | $34 |
| Furosemide | 29 | $408 | $14 |
| Cyclobenzaprine | 32 | $408 | $13 |
| Citalopram Hbr | 14 | $383 | $27 |
| Nitrostat | 11 | $367 | $33 |
| Fluticasone Propionate | 17 | $344 | $20 |
| Simvastatin | 32 | $332 | $10 |
| Hydrochlorothiazide | 39 | $327 | $8 |
| Sumatriptan | 17 | $318 | $19 |
| Amlodipine Besylate | 32 | $316 | $10 |
| Montelukast | 14 | $297 | $21 |
| Zolpidem Tartrate Er | 11 | $284 | $26 |
| Prednisone | 22 | $222 | $10 |
| Escitalopram | 17 | $216 | $13 |
| Lisinopril | 31 | $212 | $7 |
| Lorazepam | 51 | $211 | $4 |
| Alendronate | 20 | $207 | $10 |
| Lovastatin | 16 | $197 | $12 |
| Triamcinolone Acetonide | 11 | $165 | $15 |
| Ibuprofen | 22 | $152 | $7 |
| Nifedipine Er | 12 | $151 | $13 |
| Zolpidem | 19 | $129 | $7 |
| Glipizide | 11 | $124 | $11 |
| Metoprolol | 12 | $93 | $8 |
| Tramadol | 15 | $91 | $6 |
| Buspirone | 20 | $90 | $5 |
2018: 41 drugs
| Oxycontin | 17 | $8,561 | $504 |
| Advair Diskus | 11 | $6,573 | $598 |
| Desonide | 14 | $4,542 | $324 |
| Fentanyl | 21 | $2,220 | $106 |
| Oxycodone-Acetaminophen | 25 | $1,627 | $65 |
| Rosuvastatin | 19 | $1,382 | $73 |
| Ondansetron | 22 | $1,381 | $63 |
| Atorvastatin | 55 | $1,325 | $24 |
| Omeprazole | 29 | $1,078 | $37 |
| Fluocinonide | 11 | $1,016 | $92 |
| Oxycodone | 20 | $739 | $37 |
| Levothyroxine | 22 | $685 | $31 |
| Gabapentin | 20 | $627 | $31 |
| Fluoxetine | 12 | $604 | $50 |
| Simvastatin | 34 | $518 | $15 |
| Hydrocodone-Acetaminophen | 36 | $514 | $14 |
| Citalopram Hbr | 13 | $478 | $37 |
| Carvedilol | 18 | $469 | $26 |
| Cyclobenzaprine | 26 | $449 | $17 |
| Trazodone | 29 | $448 | $15 |
| Tamsulosin | 11 | $422 | $38 |
| Metoprolol | 11 | $403 | $37 |
| Amlodipine Besylate | 37 | $378 | $10 |
| Zolpidem | 33 | $335 | $10 |
| Dicyclomine | 11 | $315 | $29 |
| Baclofen | 12 | $309 | $26 |
| Metformin | 34 | $296 | $9 |
| Glipizide | 13 | $278 | $21 |
| Pantoprazole | 14 | $238 | $17 |
| Losartan | 27 | $236 | $9 |
| Furosemide | 25 | $203 | $8 |
| Lorazepam | 42 | $198 | $5 |
| Alendronate | 20 | $165 | $8 |
| Hydrochlorothiazide | 41 | $163 | $4 |
| Metoprolol | 14 | $125 | $9 |
| Naproxen | 12 | $123 | $10 |
| Buspirone | 17 | $107 | $6 |
| Atenolol | 12 | $101 | $8 |
| Ibuprofen | 15 | $95 | $6 |
| Lisinopril | 20 | $90 | $4 |
| Prednisone | 11 | $60 | $5 |
2017: 41 drugs
| Diazepam | 15 | $7,647 | $510 |
| Tradjenta | 11 | $5,828 | $530 |
| Oxycontin | 15 | $5,654 | $377 |
| Colchicine | 13 | $4,473 | $344 |
| Oxycodone-Acetaminophen | 29 | $2,282 | $79 |
| Rosuvastatin | 18 | $1,841 | $102 |
| Fentanyl | 12 | $1,550 | $129 |
| Citalopram Hbr | 32 | $1,355 | $42 |
| Levothyroxine | 41 | $1,129 | $28 |
| Omeprazole | 34 | $948 | $28 |
| Oxycodone | 18 | $809 | $45 |
| Tamsulosin | 15 | $802 | $53 |
| Fluoxetine | 16 | $797 | $50 |
| Atorvastatin | 32 | $692 | $22 |
| Metoprolol | 12 | $604 | $50 |
| Hydrocodone-Acetaminophen | 50 | $547 | $11 |
| Simvastatin | 39 | $519 | $13 |
| Gabapentin | 39 | $474 | $12 |
| Carvedilol | 15 | $396 | $26 |
| Metformin | 38 | $370 | $10 |
| Trazodone | 19 | $342 | $18 |
| Amlodipine Besylate | 36 | $328 | $9 |
| Zolpidem | 35 | $311 | $9 |
| Losartan | 26 | $284 | $11 |
| Lorazepam | 52 | $254 | $5 |
| Fluticasone Propionate | 22 | $229 | $10 |
| Alendronate | 24 | $228 | $9 |
| Benazepril | 11 | $200 | $18 |
| Buspirone | 14 | $173 | $12 |
| Furosemide | 17 | $158 | $9 |
| Spironolactone | 14 | $153 | $11 |
| Metoprolol | 19 | $149 | $8 |
| Quetiapine | 12 | $139 | $12 |
| Meclizine | 12 | $129 | $11 |
| Glipizide | 18 | $116 | $6 |
| Hydrochlorothiazide | 27 | $107 | $4 |
| Prednisone | 19 | $93 | $5 |
| Lisinopril | 17 | $80 | $5 |
| Ondansetron | 11 | $80 | $7 |
| Atenolol | 15 | $79 | $5 |
| Triamcinolone Acetonide | 12 | $71 | $6 |
2016: 36 drugs
| Colcrys | 15 | $6,779 | $452 |
| Oxycodone-Acetaminophen | 53 | $5,808 | $110 |
| Lantus Solostar | 13 | $4,993 | $384 |
| Fentanyl | 16 | $1,619 | $101 |
| Oxycodone | 27 | $1,402 | $52 |
| Levothyroxine | 35 | $932 | $27 |
| Hydrocodone-Acetaminophen | 39 | $898 | $23 |
| Metoprolol | 19 | $707 | $37 |
| Omeprazole | 49 | $682 | $14 |
| Gabapentin | 49 | $666 | $14 |
| Atorvastatin | 34 | $652 | $19 |
| Fluoxetine | 13 | $651 | $50 |
| Metformin | 55 | $562 | $10 |
| Enalapril Maleate | 13 | $562 | $43 |
| Zolpidem | 33 | $395 | $12 |
| Lorazepam | 54 | $370 | $7 |
| Benazepril | 17 | $329 | $19 |
| Simvastatin | 35 | $304 | $9 |
| Trazodone | 30 | $263 | $9 |
| Citalopram Hbr | 27 | $210 | $8 |
| Losartan | 19 | $184 | $10 |
| Allopurinol | 11 | $174 | $16 |
| Furosemide | 24 | $167 | $7 |
| Alendronate | 23 | $156 | $7 |
| Lovastatin | 22 | $127 | $6 |
| Hydrochlorothiazide | 33 | $125 | $4 |
| Ondansetron | 19 | $124 | $7 |
| Quetiapine | 13 | $122 | $9 |
| Metoprolol | 17 | $101 | $6 |
| Amlodipine Besylate | 24 | $99 | $4 |
| Ibuprofen | 15 | $96 | $6 |
| Atenolol | 15 | $90 | $6 |
| Diazepam | 12 | $88 | $7 |
| Lisinopril | 20 | $82 | $4 |
| Glipizide | 12 | $73 | $6 |
| Prednisone | 16 | $46 | $3 |
2015: 24 drugs
| Oxycodone-Acetaminophen | 33 | $3,833 | $116 |
| Oxycodone | 19 | $916 | $48 |
| Metoprolol | 14 | $915 | $65 |
| Gabapentin | 41 | $600 | $15 |
| Lorazepam | 42 | $501 | $12 |
| Levothyroxine | 23 | $421 | $18 |
| Tamsulosin | 13 | $417 | $32 |
| Metformin | 45 | $389 | $9 |
| Omeprazole | 23 | $366 | $16 |
| Quetiapine | 12 | $312 | $26 |
| Simvastatin | 27 | $303 | $11 |
| Hydrocodone-Acetaminophen | 12 | $286 | $24 |
| Citalopram Hbr | 32 | $227 | $7 |
| Trazodone | 27 | $196 | $7 |
| Amlodipine Besylate | 23 | $160 | $7 |
| Hydrochlorothiazide | 39 | $156 | $4 |
| Triamcinolone Acetonide | 17 | $138 | $8 |
| Alendronate | 18 | $138 | $8 |
| Zolpidem | 11 | $127 | $12 |
| Atenolol | 20 | $114 | $6 |
| Lovastatin | 11 | $91 | $8 |
| Lisinopril | 15 | $89 | $6 |
| Metoprolol | 12 | $73 | $6 |
| Furosemide | 15 | $66 | $4 |
2014: 45 drugs
| Oxycodone-Acetaminophen | 42 | $4,960 | $118 |
| Crestor | 15 | $3,881 | $259 |
| Namenda | 11 | $3,364 | $306 |
| Celebrex | 18 | $3,206 | $178 |
| Advair Diskus | 11 | $3,162 | $287 |
| Colcrys | 11 | $2,814 | $256 |
| Lidocaine | 11 | $2,033 | $185 |
| Omeprazole | 78 | $1,150 | $15 |
| Metoprolol | 23 | $1,087 | $47 |
| Proair Hfa | 15 | $794 | $53 |
| Labetalol | 20 | $748 | $37 |
| Fluticasone Propionate | 25 | $709 | $28 |
| Levothyroxine | 39 | $696 | $18 |
| Simvastatin | 58 | $692 | $12 |
| Valsartan-Hydrochlorothiazide | 15 | $621 | $41 |
| Pravastatin | 17 | $613 | $36 |
| Metformin | 32 | $581 | $18 |
| Gabapentin | 45 | $527 | $12 |
| Citalopram Hbr | 50 | $453 | $9 |
| Atorvastatin | 27 | $443 | $16 |
| Losartan | 42 | $432 | $10 |
| Donepezil | 30 | $396 | $13 |
| Lorazepam | 57 | $351 | $6 |
| Quetiapine | 18 | $317 | $18 |
| Lovastatin | 18 | $309 | $17 |
| Montelukast | 14 | $308 | $22 |
| Hydrochlorothiazide | 97 | $305 | $3 |
| Hydrocodone-Acetaminophen | 20 | $283 | $14 |
| Amlodipine Besylate | 44 | $281 | $6 |
| Triamcinolone Acetonide | 16 | $234 | $15 |
| Lisinopril | 25 | $226 | $9 |
| Tamsulosin | 15 | $221 | $15 |
| Methadone | 17 | $217 | $13 |
| Trazodone | 22 | $171 | $8 |
| Alendronate | 24 | $150 | $6 |
| Zolpidem | 27 | $143 | $5 |
| Ibuprofen | 20 | $135 | $7 |
| Atenolol | 25 | $133 | $5 |
| Metoprolol | 22 | $133 | $6 |
| Glimepiride | 12 | $115 | $10 |
| Carvedilol | 11 | $98 | $9 |
| Alprazolam | 20 | $92 | $5 |
| Bumetanide | 12 | $74 | $6 |
| Diazepam | 11 | $53 | $5 |
| Furosemide | 12 | $50 | $4 |
2013: 50 drugs
| Dronabinol | 11 | $9,120 | $829 |
| Namenda | 24 | $6,857 | $286 |
| Crestor | 26 | $4,485 | $173 |
| Lidoderm | 11 | $2,889 | $263 |
| Clonidine | 13 | $2,561 | $197 |
| Oxycodone Hcl-Acetaminophen | 30 | $2,096 | $70 |
| Metoprolol | 22 | $1,471 | $67 |
| Omeprazole | 96 | $1,321 | $14 |
| Morphine Sulfate Er | 19 | $1,205 | $63 |
| Gabapentin | 47 | $1,114 | $24 |
| Atorvastatin | 37 | $992 | $27 |
| Metformin | 50 | $776 | $16 |
| Proair Hfa | 12 | $656 | $55 |
| Amlodipine Besylate | 59 | $622 | $11 |
| Simvastatin | 61 | $604 | $10 |
| Hydrocodone-Acetaminophen | 29 | $565 | $19 |
| Fluticasone Propionate | 18 | $557 | $31 |
| Labetalol | 12 | $529 | $44 |
| Losartan | 44 | $529 | $12 |
| Levothyroxine | 45 | $527 | $12 |
| Zolpidem | 19 | $458 | $24 |
| Citalopram Hbr | 41 | $448 | $11 |
| Pravastatin | 22 | $402 | $18 |
| Tamsulosin | 17 | $374 | $22 |
| Lorazepam | 55 | $363 | $7 |
| Methadone | 14 | $319 | $23 |
| Trazodone | 24 | $289 | $12 |
| Hydrochlorothiazide | 80 | $285 | $4 |
| Verapamil Er | 12 | $273 | $23 |
| Lisinopril | 29 | $255 | $9 |
| Mirtazapine | 13 | $246 | $19 |
| Lovastatin | 13 | $225 | $17 |
| Donepezil | 15 | $224 | $15 |
| Triamcinolone Acetonide | 15 | $222 | $15 |
| Metoprolol | 27 | $219 | $8 |
| Oxybutynin Chloride | 13 | $153 | $12 |
| Atenolol | 31 | $149 | $5 |
| Alendronate | 20 | $144 | $7 |
| Furosemide | 24 | $139 | $6 |
| Sertraline | 13 | $122 | $9 |
| Terazosin | 12 | $114 | $9 |
| Bumetanide | 13 | $100 | $8 |
| Alprazolam | 30 | $95 | $3 |
| Glimepiride | 12 | $92 | $8 |
| Glipizide Xl | 13 | $90 | $7 |
| Diazepam | 15 | $80 | $5 |
| Warfarin | 11 | $79 | $7 |
| Temazepam | 14 | $67 | $5 |
| Glipizide | 12 | $64 | $5 |
| Metformin Hcl Er | 11 | $50 | $5 |
Professional record
- NPI
- 1962531137
- Licence
- CA A93863California A93863: Current · expires 2027-09-30
- Trained
- Temple University School of Medicine, 2004
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-03-05
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 211 Quarry Rd, Palo Alto, CA, 94304